H-MESO-1 Cells

H-MESO-1 cells are a human mesothelioma cell line derived from a patient with malignant pleural mesothelioma, a type of cancer that develops from the cells lining the lungs' or abdomen's protective lining. This cell line is extensively used in oncological research to study the biology, pathogenesis, and therapeutic strategies for mesothelioma.
H-MESO-1 cells retain several characteristics of mesothelial cells, making them a relevant model for investigating mesothelioma. They exhibit epithelioid morphology, which is one of the common histological types of mesothelioma. These cells are particularly useful for exploring the molecular pathways involved in mesothelioma development, including cell cycle regulation, apoptosis resistance, and the role of asbestos and other environmental factors in inducing mesothelioma.
In research, H-MESO-1 cells have been employed to study the interaction between mesothelioma cells and the immune system, especially considering the impact of immune checkpoint molecules and the tumor microenvironment on tumor growth and immune evasion. This cell line is also valuable for testing the efficacy of new drugs and novel immunotherapeutic approaches aimed at targeting specific pathways implicated in mesothelioma progression.
Moreover, H-MESO-1 cells are used to investigate the genetic and epigenetic alterations characteristic of mesothelioma, providing insights into potential biomarkers for early diagnosis and targets for therapeutic intervention. The cell line's responsiveness to chemotherapeutic agents and its ability to form tumors in xenograft models make it a crucial tool in developing and validating new treatment modalities for mesothelioma.